Loading clinical trials...
Loading clinical trials...
Treatment resistant depression remains a major problem for individuals and society. Surgical procedures may provide relief for some of these patients. The most frequently considered surgical approach is deep brain stimulation (DBS) of a part of the brain called the subcallosal cingulate region. However, the effectiveness and safety is not well established. The investigators will use a novel approach using advanced imaging technique (magnetic resonance tractography) to evaluate the feasibility and safety of this surgical approach. An innovative method for the definition of DBS target will be applied that redefines the concept of targeting as one of targeting a symptomatic network rather than a structural brain region using subject-based brain anatomy to define the target location. The correlation between imaging findings at baseline with the mood score changes at different time points of the study will be investigated.
Age
21 - 70 years
Sex
ALL
Healthy Volunteers
No
UT Southwestern Medical Center
Dallas, Texas, United States
Start Date
October 28, 2022
Primary Completion Date
July 1, 2027
Completion Date
July 1, 2027
Last Updated
July 2, 2025
12
ESTIMATED participants
Abbott Laboratories Infinity™ implantable deep brain stimulation system
DEVICE
Lead Sponsor
Nader Pouratian
NCT04480918
NCT04041479
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03320304